|
Product complaint #(b)(4).Date sent to the fda: 3/23/2026.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.Additional information was requested, the following was obtained: ¿ did this issue contribute to any patient adverse event? ¿ was there any additional tissue damage as a result of searching for the needle piece? ¿ what is current condition of the patient? ¿ please provide the source or name and title of external person providing answers to follow-up (external person submitting answers to sales rep or loc/bq) --received information as following from sales rep via phone today.Please refer to the event description, other information requested is unknown.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.
|
|
It was reported that a patient underwent a hysterectomy and bilateral adnexectomy under general anesthesia on (b)(6) 2026 and suture was used.During the final subcutaneous injection, the doctor discovered that the needle had broken about 1cm beneath the patient's skin.Doctor reported to the chief surgeon and first conducted an ultrasound examination, but the search was unsuccessful.Later, doctor used a c-arm machine to explore the muscle layer and found the broken needle, which was then removed.There were no patient consequences reported.Additional information was requested.
|